北京中医药大学学报2024，Vol.47Issue(10)：1449-1456,8.DOI:10.3969/j.issn.1006-2157.2024.10.015
大黄䗪虫胶囊临床合理用药评价标准的探索及应用
Exploration and application of the evaluation criterion for the clinical rational use of Dahuang Zhechong Capsule
摘要
Abstract
Objective To discuss the evaluation basis of the clinical rational use of Dahuang Zhechong Capsule and to establish its rationality evaluation criterion to promote the sensible use of Dahuang Zhechong Capsule.Methods The rationality evaluation criterion for Dahuang Zhechong Capsule was formulated by referring to the package insert,treatment guidelines,and other literature.According to the criterion,270 outpatient prescriptions using Dahuang Zhechong Capsule in Xiyuan Hospital,China Academy of Chinese Medical Sciences were reviewed from January to June 2020.The indication,usage and dosage,drug combination,and repeated administration were analyzed.The pharmaceutical intervention was performed to address the problems found in the prescription reviews,and 328 outpatient prescriptions using Dahuang Zhechong Capsule in October 2020 were reevaluated.Results The irrational use rate of Dahuang Zhechong Capsule from January to June 2020 was 42.22％(114 cases),including 108(40％)cases of inappropriate indications,five(1.85％)cases of improper usage and dosage,and one(0.37％)case of inappropriate administration route.However,the pharmaceutical intervention in October 2020 remarkably reduced the irrational use rate of Dahuang Zhechong Capsule(4.27％,14 cases),all of which were inappropriate indications.Conclusion Dahuang Zhechong Capsule is being used irrationally;therefore,establishing an evaluation criterion is required.The specific situation of irrational drug use can be identified by prescription review according to its rationality evaluation criterion to manage its clinical use better and promote its rational use.关键词
大黄䗪虫胶囊/合理用药/评价标准/门诊处方/适应证Key words
Dahuang Zhechong Capsule/rational use of drug/evaluation criterion/outpatient prescription/indication分类
医药卫生引用本文复制引用
刘津,臧旭杰,徐鹏,齐健,张天宇,付韬,苑伟,苑鹏程,冯海乐..大黄䗪虫胶囊临床合理用药评价标准的探索及应用[J].北京中医药大学学报,2024,47(10):1449-1456,8.基金项目
北京市第三批中药骨干人才培养项目 The Third Batch of Traditional Chinese Medicine Key Talent Training Project in Beijing （）
